From
to ZETA
High-Tech Plant for Antibody-Drug Conjugation
ZETA delivers cutting-edge ADC downstream processing system in record 18 months.
Innovative skid-based design and precision engineering enable safe, GMP-compliant production of high-value antibody-drug conjugates in Switzerland.
Mastered challenges.
Customized solution
Controlled freezing, transport, storage and thawing of the sensitive substances effectively accomplished.
Efficient cooling
Development of a specific vessel geometry for ultrafiltration.
Vessel cleanability
Spray ball design and cleaning procedure ensured complete toxin removal.